Matches in Wikidata for { <http://www.wikidata.org/entity/Q70495186> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q70495186 description "article scientifique publié en 1993" @default.
- Q70495186 description "artículu científicu espublizáu en payares de 1993" @default.
- Q70495186 description "im November 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70495186 description "scientific article published on 01 November 1993" @default.
- Q70495186 description "wetenschappelijk artikel" @default.
- Q70495186 description "наукова стаття, опублікована в листопаді 1993" @default.
- Q70495186 name "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 name "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 type Item @default.
- Q70495186 label "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 label "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 prefLabel "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 prefLabel "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 P1433 Q70495186-3842EE33-9A5B-49C9-AEDA-3EFB009565C8 @default.
- Q70495186 P1476 Q70495186-CC440CBE-E384-41B5-BC2B-7E8496BCF6C4 @default.
- Q70495186 P2093 Q70495186-5A9B1FFA-5FF2-4084-B1E5-AFAF8F05DAE2 @default.
- Q70495186 P2093 Q70495186-A2FE888A-C4AE-404F-B514-43E6985D5925 @default.
- Q70495186 P2093 Q70495186-C5E8E4C9-F87F-47D6-B2AC-373B0306ECFE @default.
- Q70495186 P2093 Q70495186-C8739C54-DD87-4131-BE13-AD64BF598924 @default.
- Q70495186 P304 Q70495186-0E17C0B7-8AD5-4EB2-8DB8-A0D77B87994F @default.
- Q70495186 P31 Q70495186-A4133D4F-C38F-4411-8ED5-D49CBAC689FF @default.
- Q70495186 P356 Q70495186-1AEDB370-CFAF-4BBA-9CCF-32B9DD565AC0 @default.
- Q70495186 P407 Q70495186-0208EE84-B16B-49EB-B939-A88A4C110398 @default.
- Q70495186 P433 Q70495186-7513C09F-F62F-4D3A-B105-BF7B72C8E7A2 @default.
- Q70495186 P478 Q70495186-F2B0C5A1-B979-4077-94F9-5A50A276F5A3 @default.
- Q70495186 P50 Q70495186-15ED5A0C-B1C7-4857-8A60-794BEB7DDAB4 @default.
- Q70495186 P50 Q70495186-9887F88A-9BE0-4E11-8D46-19E908615729 @default.
- Q70495186 P577 Q70495186-BD88334F-480A-4B71-AEA3-6497FD6BC8D4 @default.
- Q70495186 P698 Q70495186-C30E0EE0-7147-4F46-87A5-F3B9C616542D @default.
- Q70495186 P356 DIAB.42.11.1559 @default.
- Q70495186 P698 8405695 @default.
- Q70495186 P1433 Q895262 @default.
- Q70495186 P1476 "Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM" @default.
- Q70495186 P2093 "A Melander" @default.
- Q70495186 P2093 "C Saloranta" @default.
- Q70495186 P2093 "E Widen" @default.
- Q70495186 P2093 "M Härkönen" @default.
- Q70495186 P304 "1559-1566" @default.
- Q70495186 P31 Q13442814 @default.
- Q70495186 P356 "10.2337/DIAB.42.11.1559" @default.
- Q70495186 P407 Q1860 @default.
- Q70495186 P433 "11" @default.
- Q70495186 P478 "42" @default.
- Q70495186 P50 Q18246437 @default.
- Q70495186 P50 Q27214742 @default.
- Q70495186 P577 "1993-11-01T00:00:00Z" @default.
- Q70495186 P698 "8405695" @default.